Cowabunga
Member
- Location
- Ceredigion,Wales
From Trial Site NewsMaybe , but there's no evidence it actually works , you should have got infected for the cause .
Why isn’t ivermectin used more widely?
The great majority of regulations and national research agencies suggest more trial data is needed, and of a higher quality of data. They point out that the existing trials are either too small or not standardized enough in dosage amount or are subject to bias. Increasingly, numbers of experts speculate however that various economic interests are blocking true, open and honest debate about the potential of the drug. It could threaten a therapeutic market worth tens of billions of dollars per annum in sales.
What is the counter argument to the naysayers?
Dr. Tess Lawrie, author one of the leading meta-analyses and recent guest on the TrialSite Podcast, suggests that the meta-analyses results demonstrate safety and efficacy. Moreover, they argue the fact that some think there isn’t quite enough data is hardly a reason to stop the use of a life-saving drug.
They provide examples to drugs like remdesivir, authorized with less evidence than what various meta-analyses studying ivermectin demonstrate.
Also in detail